These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3015014

  • 1. Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.
    Shigeta S, Mori S, Yokota T, Konno K, De Clercq E.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1053-8. PubMed ID: 3015014
    [Abstract] [Full Text] [Related]

  • 2. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T, Konno K, Shigeta S, Verbruggen A, De Clercq E.
    Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
    [Abstract] [Full Text] [Related]

  • 3. Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.
    Fyfe JA.
    Mol Pharmacol; 1982 Mar; 21(2):432-7. PubMed ID: 6285172
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Shimizu K, Seno T.
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [Abstract] [Full Text] [Related]

  • 5. Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells.
    Hackstadt T, Mallavia LP.
    J Virol; 1978 Feb; 25(2):510-7. PubMed ID: 24124
    [Abstract] [Full Text] [Related]

  • 6. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R, Naesens L, Brancale A, De Clercq E, McGuigan C, Balzarini J.
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides.
    Suzutani T, Ogasawara M, Shibaki T, Azuma M.
    Antiviral Res; 2000 Jan; 45(1):79-82. PubMed ID: 10774592
    [Abstract] [Full Text] [Related]

  • 8. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE, Davis TW, Schupp JE, Hwang HS, de Wind N, Kinsella TJ.
    Cancer Res; 2000 Oct 15; 60(20):5773-80. PubMed ID: 11059773
    [Abstract] [Full Text] [Related]

  • 9. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine.
    Kodama E, Mori S, Shigeta S.
    Antiviral Res; 1995 May 15; 27(1-2):165-70. PubMed ID: 7486953
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E, Descamps J, Ogata M, Shigeta S.
    Antimicrob Agents Chemother; 1982 Jan 15; 21(1):33-8. PubMed ID: 6282207
    [Abstract] [Full Text] [Related]

  • 11. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN, Keller PM, Fyfe JA, Martin JL, Rooney JF, Straus SE, Lehrman SN, Barry DW.
    Antimicrob Agents Chemother; 1987 Jul 15; 31(7):1117-25. PubMed ID: 2821890
    [Abstract] [Full Text] [Related]

  • 12. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
    Kit S, Ichimura H, De Clercq E.
    Antiviral Res; 1987 Aug 15; 8(1):41-51. PubMed ID: 2825591
    [Abstract] [Full Text] [Related]

  • 13. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC, Dutschman G, De Clercq E, Jones AS, Rahim SG, Verhelst G, Walker RT.
    Mol Pharmacol; 1981 Jul 15; 20(1):230-3. PubMed ID: 6270535
    [No Abstract] [Full Text] [Related]

  • 14. Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.
    Descamps J, De Clercq E.
    J Biol Chem; 1981 Jun 25; 256(12):5973-6. PubMed ID: 6263899
    [Abstract] [Full Text] [Related]

  • 15. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T, Konno K, Shigeta S, De Clercq E.
    Mol Pharmacol; 1984 Sep 25; 26(2):376-80. PubMed ID: 6090888
    [Abstract] [Full Text] [Related]

  • 16. Antiviral activity of oxetanocins against varicella-zoster virus.
    Sakuma T, Saijo M, Suzutani T, Yoshida I, Saito S, Kitagawa M, Hasegawa S, Azuma M.
    Antimicrob Agents Chemother; 1991 Jul 25; 35(7):1512-4. PubMed ID: 1656865
    [Abstract] [Full Text] [Related]

  • 17. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.
    Roberts GB, Fyfe JA, Gaillard RK, Short SA.
    J Virol; 1991 Dec 25; 65(12):6407-13. PubMed ID: 1658351
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.
    Shigeta S, Yokota T, Iwabuchi T, Baba M, Konno K, Ogata M, De Clercq E.
    J Infect Dis; 1983 Mar 25; 147(3):576-84. PubMed ID: 6300257
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T, Konno K, Mori S, Shigeta S, Kumagai M, Watanabe Y, Machida H.
    Mol Pharmacol; 1989 Aug 25; 36(2):312-6. PubMed ID: 2549386
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N, Watanabe Y, Miura S, Kano F, Sakata S, Yamaguchi T, Suzutani T, Machida H.
    Antiviral Res; 1997 Aug 25; 35(3):167-75. PubMed ID: 9298756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.